✓ Η πληρωμή με πιστωτική κάρτα αποκαταστάθηκε — ασφαλής ολοκλήρωση αγοράς μέσω Privacy Shield

Θεραπεία για τις Γεννητικές Κονδυλώσεις

Εμφάνιση του μοναδικού αποτελέσματος

+
Αυτό το προϊόν έχει πολλαπλές παραλλαγές. Οι επιλογές μπορούν να επιλεγούν στη σελίδα του προϊόντος Γρήγορη προβολή
Εύρος τιμών: από US$36.00 έως US$100.00

Genital warts are caused by human papillomavirus (HPV) types 6 and 11 in over 90% of cases — non-cancerous but cosmetically and psychologically distressing, with high transmission rate to partners. Treatment options include topical immune-response modifiers (imiquimod), cytotoxic agents (podophyllotoxin), and clinic-based ablation (cryotherapy, electrocautery, laser, surgical excision).

Διαθέσιμη επιλογή. Imiquimod 5% cream is the most-used topical immunotherapy for external genital warts. Apply to wart areas at bedtime three times weekly (alternate nights) for up to 16 weeks; wash off in the morning (6–10 hours after application). Stocked as Imiquad Κρέμα. Side-effects: local erythema, erosion, itching, burning — these are part of the immune response and signal effective treatment. Recurrence is possible; partners should be examined and treated as needed. Podophyllotoxin solution (an alternative cytotoxic agent for self-application) is not currently in our routine stock.

Οδηγίες χρήσης. External anogenital warts in non-pregnant adults → imiquimod 5% cream three nights per week, up to 16 weeks. Pregnancy → cryotherapy or trichloroacetic acid in clinic; do not use imiquimod or podophyllotoxin in pregnancy. Vaginal, cervical, anal, or urethral warts → specialist gynaecology / colorectal / urology referral for clinic-based treatment. Large or refractory lesions → ablative treatment ± biopsy.

Σημαντικό. Genital warts diagnosis warrants STI screening (HIV, syphilis, chlamydia, gonorrhoea, hepatitis B/C). HPV vaccination (Gardasil 9, available through public health programmes in many countries) reduces but does not eliminate recurrence risk and is not effective treatment for established warts. Cervical screening remains essential for women — high-risk HPV types (16, 18, others) cause cervical cancer; the wart-causing low-risk types (6, 11) do not. Persistent or atypical lesions warrant biopsy to exclude pre-malignant change. All MedsBase products ship from WHO-GMP πιστοποιημένους κατασκευαστές με διακριτική συσκευασία και καλύπτονται από την Πολιτική Εγγύησης Επαναποστολής.